Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc (APLS) is known on NASDAQ - United States, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerAPLS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Financial periodQ1 2026
- RevenueUSD 268.30M
- Net incomeUSD 133.27M
- Free cash flowUSD 37.47M
- Gross margin371.6%